Literature DB >> 16915145

Lymphangioleiomyomatosis.

Francis X McCormack1.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16915145      PMCID: PMC1682009     

Source DB:  PubMed          Journal:  MedGenMed        ISSN: 1531-0132


× No keyword cloud information.
  42 in total

1.  Pulmonary mechanics in lymphangioleiomyomatosis.

Authors:  C D Burger; R E Hyatt; B A Staats
Journal:  Am Rev Respir Dis       Date:  1991-05

2.  Pulmonary lymphangiomyomatosis. A review.

Authors:  B Corrin; A A Liebow; P J Friedman
Journal:  Am J Pathol       Date:  1975-05       Impact factor: 4.307

3.  Lymphangioleiomyomatosis. Physiologic-pathologic-radiologic correlations.

Authors:  C B Carrington; D W Cugell; E A Gaensler; A Marks; R A Redding; J T Schaaf; A Tomasian
Journal:  Am Rev Respir Dis       Date:  1977-12

4.  Pulmonary lymphangiomyomatosis responsive to progesterone.

Authors:  K S McCarty; J A Mossler; R McLelland; H O Sieker
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

5.  Pulmonary lymphangioleiomyomatosis and steroid receptors. An immunocytochemical study.

Authors:  U Berger; A Khaghani; A Pomerance; M H Yacoub; R C Coombes
Journal:  Am J Clin Pathol       Date:  1990-05       Impact factor: 2.493

6.  Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis.

Authors:  Toshio Kumasaka; Kuniaki Seyama; Keiko Mitani; Teruhiko Sato; Sanae Souma; Takashi Kondo; Seiji Hayashi; Masato Minami; Toshimasa Uekusa; Yoshinosuke Fukuchi; Koichi Suda
Journal:  Am J Surg Pathol       Date:  2004-08       Impact factor: 6.394

Review 7.  Metastasis of benign tumor cells in tuberous sclerosis complex.

Authors:  Elizabeth Petri Henske
Journal:  Genes Chromosomes Cancer       Date:  2003-12       Impact factor: 5.006

Review 8.  Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes.

Authors:  James Brugarolas; William G Kaelin
Journal:  Cancer Cell       Date:  2004-07       Impact factor: 31.743

9.  Immunohistochemical detection of steroid receptors in a case of pulmonary lymphangioleiomyomatosis.

Authors:  M H Colley; E Geppert; W A Franklin
Journal:  Am J Surg Pathol       Date:  1989-09       Impact factor: 6.394

10.  TSC2 regulates VEGF through mTOR-dependent and -independent pathways.

Authors:  James B Brugarolas; Francisca Vazquez; Archana Reddy; William R Sellers; William G Kaelin
Journal:  Cancer Cell       Date:  2003-08       Impact factor: 31.743

View more
  6 in total

1.  Reader's response to "lymphangioleiomyomatosis".

Authors:  Ellen C G Grant
Journal:  MedGenMed       Date:  2006-03-24

Review 2.  The role of chemokines in migration of metastatic-like lymphangioleiomyomatosis cells.

Authors:  Gustavo Pacheco-Rodriguez; Joel Moss
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

3.  Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis.

Authors:  Xiong Cai; Gustavo Pacheco-Rodriguez; Qing-Yuan Fan; Mary Haughey; Leigh Samsel; Souheil El-Chemaly; Hai-Ping Wu; J Philip McCoy; Wendy K Steagall; Jing-Ping Lin; Thomas N Darling; Joel Moss
Journal:  Am J Respir Crit Care Med       Date:  2010-07-16       Impact factor: 21.405

4.  Neutrophil elastase from myeloid cells promotes TSC2-null tumor growth.

Authors:  Manisha Taya; Maria de la Luz Garcia-Hernandez; Javier Rangel-Moreno; Briaunna Minor; Erin Gibbons; Stephen R Hammes
Journal:  Endocr Relat Cancer       Date:  2020-04       Impact factor: 5.678

Review 5.  Current management of tuberous sclerosis complex.

Authors:  Darcy A Krueger; David N Franz
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

6.  Efficacy of sirolimus for the prevention of recurrent pneumothorax in patients with lymphangioleiomyomatosis: a case series.

Authors:  Li Zhou; Ruoyun Ouyang; Hong Luo; Siying Ren; Ping Chen; Yating Peng; Ting Liu; Guiqian Liu
Journal:  Orphanet J Rare Dis       Date:  2018-09-21       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.